Want to join the conversation?
During 3Q15, $AIV's AFFO was $0.48 per share, which was a penny ahead at the high end of its guidance range and FFO was $0.57 per share, which exceeded the midpoint of its guidance range by $0.01. Additionally, $AIV has 24 unencumbered apartment communities with an estimated fair market value of around $1.5Bil at the end of 3Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.